Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02140840
Title A Phase II Open-Label, Multiple-Dose, Single Agent Study to Evaluate the Overall Response Rate of Orally Administered Trametinib
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Arkansas

multiple myeloma



Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST